Nifty
Sensex
:
:
22795.90
75311.06
-117.25 (-0.51%)
-424.90 (-0.56%)

Chemicals

Rating :
N/A

BSE: 543271 | NSE: JUBLINGREA

723.10
06-Feb-2025
  • Open
  • High
  • Low
  • Previous Close
  •  744.00
  •  753.90
  •  717.00
  •  743.80
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  457345
  •  3353.73
  •  885.00
  •  422.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,815.99
  • 52.41
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 11,466.21
  • 0.74%
  • 3.75

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.47%
  • 2.11%
  • 19.17%
  • FII
  • DII
  • Others
  • 6.89%
  • 14.57%
  • 5.79%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -5.81

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -12.73

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -27.34

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 25.22

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 3.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 15.96

Earnings Forecasts:

Description
2024
2025
2026
2027
Adj EPS
11.56
15.98
21.59
27.28
P/E Ratio
64.75
46.83
34.67
27.43
Revenue
4136
4572
5304
5981
EBITDA
424
544
688
838
Net Income
183
254
343
433
ROA
4.1
6.8
9.2
11.3
P/Bk Ratio
4.36
4.04
3.72
3.35
ROE
6.77
8.87
11.03
12.57
FCFF
-205.56
-49.54
-72.02
257.04
FCFF Yield
-1.65
-0.4
-0.58
2.06

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Net Sales
1,056.77
966.40
9.35%
1,045.24
1,019.94
2.48%
1,024.34
1,075.02
-4.71%
1,074.44
1,144.98
-6.16%
Expenses
918.48
870.83
5.47%
920.67
902.28
2.04%
914.81
958.37
-4.55%
983.20
1,042.93
-5.73%
EBITDA
138.29
95.57
44.70%
124.57
117.66
5.87%
109.53
116.65
-6.10%
91.24
102.05
-10.59%
EBIDTM
13.09%
9.89%
11.92%
11.54%
10.69%
10.85%
8.49%
8.91%
Other Income
9.43
8.78
7.40%
10.46
8.52
22.77%
9.57
8.50
12.59%
9.50
9.00
5.56%
Interest
12.39
15.06
-17.73%
15.07
12.52
20.37%
14.27
11.46
24.52%
13.62
5.70
138.95%
Depreciation
39.76
34.24
16.12%
39.60
33.91
16.78%
38.88
32.30
20.37%
35.72
29.84
19.71%
PBT
95.57
55.05
73.61%
80.36
79.75
0.76%
65.95
81.39
-18.97%
51.40
75.51
-31.93%
Tax
26.20
16.52
58.60%
21.22
22.38
-5.18%
17.29
23.72
-27.11%
22.10
23.21
-4.78%
PAT
69.37
38.53
80.04%
59.14
57.37
3.09%
48.66
57.67
-15.62%
29.30
52.30
-43.98%
PATM
6.56%
3.99%
5.66%
5.62%
4.75%
5.36%
2.73%
4.57%
EPS
4.39
2.44
79.92%
3.73
3.64
2.47%
3.08
3.64
-15.38%
1.85
3.29
-43.77%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Net Sales
4,200.79
4,135.80
4,772.69
4,949.36
684.13
0.00
Net Sales Growth
-0.13%
-13.34%
-3.57%
623.45%
0
 
Cost Of Goods Sold
2,170.26
2,142.59
2,581.57
2,839.89
369.95
0.00
Gross Profit
2,030.53
1,993.21
2,191.11
2,109.47
314.18
0.00
GP Margin
48.34%
48.19%
45.91%
42.62%
45.92%
0
Total Expenditure
3,737.16
3,714.68
4,225.55
4,117.54
567.01
0.17
Power & Fuel Cost
-
521.15
709.11
468.23
51.71
0.00
% Of Sales
-
12.60%
14.86%
9.46%
7.56%
0
Employee Cost
-
383.94
343.48
327.28
49.02
0.00
% Of Sales
-
9.28%
7.20%
6.61%
7.17%
0
Manufacturing Exp.
-
275.14
288.14
236.16
56.37
0.00
% Of Sales
-
6.65%
6.04%
4.77%
8.24%
0
General & Admin Exp.
-
146.40
89.68
81.60
12.08
0.17
% Of Sales
-
3.54%
1.88%
1.65%
1.77%
0
Selling & Distn. Exp.
-
207.23
177.84
124.85
21.96
0.00
% Of Sales
-
5.01%
3.73%
2.52%
3.21%
0
Miscellaneous Exp.
-
38.23
35.73
39.52
5.91
0.00
% Of Sales
-
0.92%
0.75%
0.80%
0.86%
0
EBITDA
463.63
421.12
547.14
831.82
117.12
-0.17
EBITDA Margin
11.04%
10.18%
11.46%
16.81%
17.12%
0
Other Income
38.96
35.30
33.37
31.49
2.60
0.00
Interest
55.35
52.66
21.58
30.94
7.33
0.00
Depreciation
153.96
136.17
122.18
123.39
22.06
0.00
PBT
293.28
267.60
436.75
708.99
90.33
-0.17
Tax
86.81
84.72
129.22
232.23
23.03
0.00
Tax Rate
29.60%
31.66%
29.59%
32.76%
29.76%
0.00%
PAT
206.47
182.89
307.50
476.71
54.36
-0.17
PAT before Minority Interest
206.47
182.89
307.50
476.71
54.36
-0.17
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.92%
4.42%
6.44%
9.63%
7.95%
0
PAT Growth
0.29%
-40.52%
-35.50%
776.95%
-
 
EPS
12.96
11.48
19.30
29.93
3.41
-0.01

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Shareholder's Funds
2,737.47
2,666.23
2,433.12
1,922.94
-0.12
Share Capital
15.80
15.90
15.90
15.93
0.05
Total Reserves
2,712.14
2,646.32
2,415.78
1,907.01
-0.17
Non-Current Liabilities
695.62
403.19
296.32
548.86
0.00
Secured Loans
425.57
150.00
99.69
455.84
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
64.81
66.13
67.93
69.44
0.00
Current Liabilities
1,286.08
1,179.58
1,052.78
894.33
0.17
Trade Payables
766.67
801.12
797.77
694.06
0.17
Other Current Liabilities
195.23
110.17
101.60
183.03
0.00
Short Term Borrowings
283.00
246.73
129.06
0.00
0.00
Short Term Provisions
41.18
21.56
24.34
17.24
0.00
Total Liabilities
4,719.17
4,249.00
3,782.22
3,366.13
0.05
Net Block
2,538.71
1,846.18
1,798.28
1,805.10
0.00
Gross Block
3,443.76
2,625.80
2,462.87
2,352.65
0.00
Accumulated Depreciation
905.04
779.62
664.59
547.56
0.00
Non Current Assets
2,939.27
2,430.99
2,017.65
1,942.54
0.00
Capital Work in Progress
331.35
524.93
174.22
65.08
0.00
Non Current Investment
15.49
8.23
6.19
50.24
0.00
Long Term Loans & Adv.
33.22
42.67
25.86
21.63
0.00
Other Non Current Assets
20.49
8.97
13.11
0.50
0.00
Current Assets
1,779.90
1,818.00
1,764.57
1,423.59
0.05
Current Investments
0.00
0.00
0.00
0.00
0.00
Inventories
941.30
1,035.11
911.16
609.10
0.00
Sundry Debtors
571.97
510.89
580.91
471.03
0.00
Cash & Bank
79.60
84.59
48.53
116.60
0.05
Other Current Assets
187.03
39.26
83.05
79.91
0.00
Short Term Loans & Adv.
139.50
148.16
140.92
146.95
0.00
Net Current Assets
493.83
638.43
711.79
529.26
-0.12
Total Assets
4,719.17
4,248.99
3,782.22
3,366.13
0.05

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Cash From Operating Activity
429.98
462.46
452.74
112.28
0.00
PBT
267.61
436.71
708.94
77.39
-0.17
Adjustment
202.50
148.28
174.29
45.45
0.00
Changes in Working Capital
5.87
-45.15
-302.39
0.95
0.17
Cash after chg. in Working capital
475.98
539.84
580.84
123.79
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
-46.00
-77.38
-128.10
-11.51
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-568.78
-471.89
-71.86
-43.66
0.00
Net Fixed Assets
-340.05
-466.36
-217.18
-2,299.50
Net Investments
-125.07
-32.70
-4.30
-134.89
Others
-103.66
27.17
149.62
2,390.73
Cash from Financing Activity
144.13
41.60
-417.75
-72.36
0.05
Net Cash Inflow / Outflow
5.34
32.17
-36.87
-3.74
0.05
Opening Cash & Equivalents
72.72
37.61
73.34
0.05
0.00
Closing Cash & Equivalent
78.78
72.72
37.61
73.34
0.05

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Book Value (Rs.)
172.66
167.47
152.96
120.73
-2.32
ROA
4.08%
7.66%
13.34%
3.23%
-332.00%
ROE
6.79%
12.07%
21.89%
5.65%
0.00%
ROCE
9.80%
16.01%
28.84%
6.86%
0.00%
Fixed Asset Turnover
1.37
1.88
2.06
0.29
0.00
Receivable days
47.67
41.69
38.75
250.55
0.00
Inventory Days
87.01
74.31
56.00
323.99
0.00
Payable days
133.54
113.03
95.87
342.47
0.00
Cash Conversion Cycle
1.13
2.97
-1.12
232.07
0.00
Total Debt/Equity
0.27
0.15
0.09
0.28
0.00
Interest Cover
6.08
21.24
23.92
11.56
0.00

News Update:


  • Jubilant Ingrevia - Quarterly Results
    28th Jan 2025, 13:55 PM

    Read More
  • Jubilant Ingrevia commissions new cGMP compliant facility in Gujarat
    25th Jan 2025, 14:28 PM

    The facility is an extension of the company’s USFDA approved plant that is already supplying to the U.S., Europe, Japan and many other markets

    Read More
  • Jubilant Ingrevia’s arm gets nod to purchase 6.67% stake in Forum I Aviation
    31st Dec 2024, 09:30 AM

    The company at its Board Meeting held on December 30, 2024 has approved the same

    Read More
  • Jubilant Ingrevia raises Rs 48 crore through Commercial Papers
    27th Dec 2024, 17:45 PM

    Tenure of the instrument is 60 days

    Read More
  • Jubilant Ingrevia raises Rs 100 crore through commercial papers
    12th Dec 2024, 11:57 AM

    The maturity of the said Commercial Papers will be on February 24, 2025

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.